Algal enzyme synthesizes gasoline building blocks
An algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels.
ADVERTISEMENT
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1996 entries already.
An algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels.
EQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m.
Antisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
The latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.
Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.
Munich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital.
Serum-supplemented cell culture media remains the gold standard for obtaining near in vivo conditions. Thats why we have expanded our product line to include GMP-grade Human AB Serum.
The Berlin-Brandenburg capital region is one of the leading life science regions in Europe and a lot is being done to keep it that way: with a wide variety of space offerings and support programs for founders and start-ups.
The 13th edition of the European Biotechnology Science & Industry Guide is showcasing brilliant science and excellent business from companies, universities, research institutes, and expert support providers. In addition to the detailed portraits on approx. 188 colored pages, the guide features a report about sustainibility and the biologisation of industrial production. Readers will discover many success stories and current trends in the European biotech industry.
How to stop hard-to-diagnose, treatment-resistant microbial pathogens was discussed by experts from 13 countries at the 7th AMR Conference in Basel.